Abstract
A modification of Berstad's spectrophotometric method was tested and proved capable of detecting pepsin concentrations in mucosal perendoscopic biopsy homogenates. The relationship between this parameter and pepsin in gastric juice and pepsinogen group I in serum and in biopsy homogenates was analyzed. From the biochemical point of view, the assay was found sufficiently accurate. Mucosal pepsinogen group I, but not mucosal pepsin, concentration was found higher in gastric and duodenal ulcer patients than in controls. Patients with corpus-fundic gastric ulcer showed significantly lower mucosal pepsin and mucosal pepsinogen group (PG) I. Aging and smoking did not influence either parameter but male duodenal ulcer subjects presented higher mucosal pepsinogen group I concentration. The lack of any relationship between serum and mucosal PG I and between pepsin in gastric juice and in mucosa raises a question, at least in methodological terms, about the validity of using serum pepsinogen group I and pepsin as indicators of peptic output.
Similar content being viewed by others
References
Ohe K, Ueno N, Yokoya, H, Miyoshi A: The activation of pepsinogen inside the gastric mucosa caused by the hydrogen ion back-diffusion during the course of aspirin ulceration. Hiroshima J Med Sci 28:1–11, 1979
Ford TF, Grant D, Austen BM, Hermon-Taylor J: Intramucosal activation of pepsinogens in the pathogenesis of acute gastric erosions and their prevention by the potent semisynthetic amphipatic inhibitor pepstatinyl-glycyl-lysyl-lysine. Clin Chim Acta 145:37–47, 1985
Joffe SN, Roberts NB, Taylor WH, Baron JH: Exogenous and endogenous acid and pepsin in the pathogenesis of duodenal ulcers in the rat. Dig Dis Sci 25:837–841, 1980
Samloff IM: Peptic ulcer: The many proteinases of aggression. Gastroenterology 96:586–595, 1989
Nagashima R, Samloff IM: Aggressive factors II: Pepsin.In Peptic Ulcer Disease. FP Brooks, S Cohen, RD Soloway (eds). New York, Churchill Livingstone, 1985, pp 181–214
Walker P, Luther J, Samloff IM, Feldman M: Life events, stress and psychosocial factors in man with peptic ulcer disease II. Relationships with serum pepsinogen concentration, family history of ulcer and behavioral factors. Gastroenterology 94:323–330, 1988
Samloff IM, Liebman WM, Panitch NM: Serum group I pepsinogen by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 69:83–90, 1975
Plebani M, Di Mario F, Vianello F, Giordano A, Masiero M, Lazzaretto M, Farini R, Ceriotti G, Naccarato R: Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: A comparative study in normal subjects and in peptic ulcer patients. Clin Biochem 16:20–22, 1983
Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H, Oka H, Matsushima T, Talahashi K: Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 126:183–191, 1982
Vianello F, Plebani M, Piccoli A, Tessaro P, Di Mario F, Naccarato R, Burlina A: Role of serum pepsinogen in detecting ulcer disease. Clin Chim Acta 172:335–340, 1988
Rotter JI, Petersen GM, Samloff IM, McConnel RB, Ellis A, Spence MA, Rimoin DL: Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med 300:63–65, 1979
Rotter JI, Sones JW, Samloff IM, Richardson CT, Gursky JM, Walsh JH, Rimoin DL: Duodenal ulcer disease associated with elevated serum pepsinogen I: An inherited autosomal dominant disorder. N Engl J Med 300:63–65, 1979
Petersen GM, Lam SK, Samloff IM, Jing J, Rotter JI: Genetic factors predict duodenal ulcer healing. Gastroenterology 88:1538, 1985 (abstract)
Lee FI, Samloff IM, Hardmann M: Comparison of tripotassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1:1299–1301, 1985
Battaglia G, Farini R, Di Mario F, Piccoli A, Plebani M, Vianello F, Burlina A, Naccarato R: Recurrence of duodenal ulcer under continuous antisecretory treatment: An approach to the detection of predictive markers. Am J Gastroenterol 79:831–834, 1984
Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A: Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 90:570–576, 1986
Habibullah CM, Mujamid Ali M, Ishaq M, Prajad R, Pratap B, Saleem Y: Study of duodenal ulcer disease in 100 families using total serum pepsinogen as a genetic marker. Gut 25:1380–1383, 1984
Waldum HL, Burhol PG, Straume BK: Serum group I pepsinogen and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin. Scand J Gastroenterol 13:943–946, 1978
Massarat J: Serum pepsin as a parameter of gastric acid secretion. Hepatogastroenterology 32:185–190, 1985
Pearson JP, Ward R, Allen A, Roberts NB, Tylor WM: Mucus degradation by pepsin: Comparison of mucolytic activity of human pepsin 1 and pepsin 3: Implications in peptic ulceration. Gut 27:243–248, 1986
Taylor WH: Pepsins of patients with peptic ulcer. Nature 227:76–77, 1970
Walker V, Taylor WH: Pepsin 1 secretion in chronic peptic ulceration. Gut 21:766–771, 1980
Walker V, Taylor WH: Cigarette smoking, chronic peptic ulceration and pepsin 1 secretion. Gut 20:971–976, 1979
Achord JL: Comparison of basal gastric acid and pepsin output in controls vs active peptic ulcer disease. Am J Gastroenterol 70:46–49, 1978
Miki K, Ichinose M, Furihata C, Niwa H, Oka H, Oda T, Tatsushima T: Potential peptic activity of pepsinogen of human gastroduodenal mucosa determined by fluorescent microassay method using succinyl-albumin. Clin Chim Acta 121:337–344, 1982
Ford TF, Hermon-Taylor J, Grant DAW: A sensitive fluorimetric assay for simultaneous estimation of pepsin and pepsinogen in gastric mucosa. Clin Chim Acta 126:17–23, 1982
Hengels KJ, Heinrich G, Strohmeyer G: Relationship between peptic cells mass, mucosal pepsinogen concentration and pepsinogen secretion in normal gastric mucosa and gastritis. Dig Dis Sci 31:1457, 1986 (abstr)
Plebani M, Di Mario F, Dal Santo P, Faggian D, Germanà B, Vianello F, Naccarato R, Burlina A: Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies. Clin Chem 36(4):682–684, 1990
Berstad D: A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand J Gastroenterol 5:343–349, 1970
Bradford MA: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–251, 1976
Becker T, Rapp W: Characterization of human pepsin I obtained from purified gastric pepsinogen II. Klin Wochenschr 57:711–718, 1979
Becker T, Rapp W: Characterization of human pepsin II obtained from purified gastric pepsinogen II. Klin Wochenschr 57:719–724, 1979
Samloff IM, Taggart RT, Shiraishi T, Branch T, Reid WA, Heath R, Lewis RW, Valler MJ, Ray J: Slow moving proteinase: isolation, characterization and immunohistochemical localization in gastric mucosa. Gastroenterology 993:77–84, 1987
Roberts NB, Taylor WH: Isolation and properties of a non-pepsin proteinase from human gastric mucosa. Biochem J 169:617–624, 1978
Venables CW: Mucus pepsin and peptic ulcer. Gut 27:233–238, 1986
Pals G, Rasanen V, Meuwissen SGM, Frants RR, Kostense PJ, Eriksson AW: Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen 1. Scand J Clin Lab Invest 47:29–33, 1987
Foltmann B: Purification, structure and activation of pepsinogen.In Pepsinogens in Man: Clinical and Genetic Advances. J Kreuning, IM Samloff, JI Rotter, AW Eriksson (eds). New York, Alan R Liss, 1985, pp 1–13
Libman LJ, Samloff IM: Quantitative distribution of pepsinogens I and II in gastric mucosa. Gastroenterology 74:1132, 1978 (abstract)
Sarosiek J, Slomiany A, Slomiany BL: Evidence for weakening of gastric mucus integrity byCampylobacter pylori. Scand J Gastroenterol 23:585–590, 1988
Pejre S, Di Napoli A, Pelissero A, Sategna Guidetti C: Diagnostic usefulness of serum group I pepsinogen determination. Gastroenterol Clin Biol 7:793–798, 1983
Plebani M, Di Mario F, Vianello F, Farini R, Piccoli A, Lazzaretto L, Perobelli L, Naccarato R, Burlina A: Actual role of pepsinogen group I in the study of upper gastrointestinal disease. Clin Biochem 16:310–312, 1983
Rotter JI, Rimoin DL: Peptic ulcer disease—a heterogeneous group of disorders? Gastroenterology 73:604–607, 1977
Hirschowitz BI: Apparent and intrinsic sensitivity to pentagastrin of acid and peptic secretion in peptic ulcer. Gastroenterology 86:843–851, 1984
Malesci A, Basilico M, Bonato C, Marchi R, Tittobello A: Smoking and serum pepsinogen I in duodenal ulcer. Scand J Gastroenterol 17(suppl 78):981, 1982
Pelissero A, Di Napoli A, Peyre S, Sategna Guidetti S: Serum group I pepsinogens levels in normal adults. J Clin Gastroenterol 4:499, 1986
Massarrat S, Enschai F, Pittner PM: Increased gastric secretory capacity in smokers without gastro-intestinal lesions. Gut 27:433–439, 1986
Debas HT, Cohen NM, Holubitsky IB, Harrison RC: Effect of cigarette smoking on human gastric secretory responses. Gut 12:93–96, 1971
Parente F, Lazzaroni M, Sangaletti O, Baroni S, Bianchi Porro G: Cigarette smoking, gastric acid secretion and serum pepsinogen I concentrations in duodenal ulcer patients. Gut 26:1327–1332, 1985
Author information
Authors and Affiliations
Additional information
This study was performed under the auspices of the “R. Farini Foundation for Gastroenterological Research.”
Rights and permissions
About this article
Cite this article
Vianello, F., Di Mario, F., Plebani, M. et al. Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease. Digest Dis Sci 39, 301–308 (1994). https://doi.org/10.1007/BF02090201
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02090201